Literature DB >> 6282297

Prolonged converting enzyme inhibition following captopril in patients with renal insuffficiency.

B C Campbell, A N Shepherd, H L Elliott, K McLean, J L Reid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282297      PMCID: PMC1402068          DOI: 10.1111/j.1365-2125.1982.tb01455.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.

Authors:  S G Chiknas
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

3.  The measurement of angiotensin-converting enzyme in subjects receiving captopril.

Authors:  J E Roulston; G A MacGregor
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

Review 4.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

5.  Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

Authors:  B C Campbell; A N Shepherd; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

6.  Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.

Authors:  F Boomsma; J H de Bruyn; F H Derkx; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1981-05       Impact factor: 6.124

7.  Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.

Authors:  K Onoyama; H Hirakata; K Iseki; S Fujimi; T Omae; M Kobayashi; Y Kawahara
Journal:  Hypertension       Date:  1981 Jul-Aug       Impact factor: 10.190

  7 in total
  4 in total

Review 1.  Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.

Authors:  P A Van Zwieten; A De Jonge; P B Timmermans
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

2.  Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  N Hockings; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

3.  Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.

Authors:  J F Giudicelli; M Chaignon; C Richer; B Giroux; J Guedon
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

4.  The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function.

Authors:  O H Drummer; B S Workman; P J Miach; B Jarrott; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.